Name
MAZE
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for MAZE
Name
Alternate Names
Dom-Etoposide
Epipodophyllotoxin derivative
Epipodophyllotoxin ethylidene gluco-pyranoside
Eposine
Ethylidene-Lignan P
Etopophos
Podophyllotoxin derivative
Vepesid
VP 16-213
VP-16
VP-16213
Toposar
Abbreviations
EPEG
VP-16
VP-16-213
Category
Chemotherapy
Subcategory
Epipodophyllotoxin, topoisomerase II inhibitor
Plant alkaloid
NSC Number
141540
Primary Site
Gastric cancer
Hodgkins lymphoma
Lung cancer (NSCLC, SCLC)
Non-Hodgkin lymphoma
testicular cancer (Germ cell tumors)
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
496
5-Azacitidine
5-Azacytidine
Antibiotic U-18
AZA-CR
Azacytidine
Ladakamycin
Mylosar
Vidaza
Abbreviations
5-AC
5-AZA
5-AZAC
5-AZCR
AZC
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
102816
Primary Site
Leukemia
Histology
None
Remarks
Phase II/III MDS, Phase I AML Antineoplastic agent; reduction in size or spread of neoplasm; improvement in hematologic parameters;bone marrow aspirate; antimetabolite; also differentiation inducing agent. NCI
Coding
This drug should be coded
Home